TreeWAS – Cluster: X0186

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	No effect posterior probability	Protective posterior probability
F10.2 Dependence syndrome	0.000	1.000
F10 Mental and behavioural disorders due to use of alcohol	0.000	1.000
I25 Chronic ischaemic heart disease	0.000	1.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	1.000
T80-T88 Complications of surgical and medical care, not elsewhere classified	0.000	1.000
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.000	1.000
Z95 Presence of cardiac and vascular implants and grafts	0.000	1.000
I10 Essential (primary) hypertension	0.000	1.000
F10.1 Harmful use	0.000	1.000
I25.2 Old myocardial infarction	0.000	1.000
Chapter IX Diseases of the circulatory system	0.000	1.000
I20-I25 Ischaemic heart diseases	0.000	1.000
Z95.5 Presence of coronary angioplasty implant and graft	0.000	1.000
S00-S09 Injuries to the head	0.000	1.000
# Top node	0.000	1.000
Z95.1 Presence of aortocoronary bypass graft	0.001	0.999
T84 Complications of internal orthopaedic prosthetic devices, implants and grafts	0.001	0.999
I10-I15 Hypertensive diseases	0.001	0.999
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.001	0.999
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.001	0.999
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.001	0.999
Chapter V Mental and behavioural disorders	0.001	0.999
I25.1 Atherosclerotic heart disease	0.001	0.999
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.001	0.999
T51 Toxic effect of alcohol	0.001	0.999
F10.0 Acute intoxication	0.002	0.998
T51.0 Ethanol	0.002	0.998
Z95.8 Presence of other cardiac and vascular implants and grafts	0.002	0.998
I25.8 Other forms of chronic ischaemic heart disease	0.002	0.998
I25.9 Chronic ischaemic heart disease, unspecified	0.002	0.998
T42.4 Benzodiazepines	0.003	0.997
T82 Complications of cardiac and vascular prosthetic devices, implants and grafts	0.007	0.993
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.009	0.991
Chapter VI Diseases of the nervous system	0.010	0.990
S00 Superficial injury of head	0.013	0.987
T84.8 Other complications of internal orthopaedic prosthetic devices, implants and grafts	0.013	0.987
T39.1 4-Aminophenol derivatives	0.015	0.985
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts	0.016	0.984
T81 Complications of procedures, not elsewhere classified	0.019	0.981
T43.2 Other and unspecified antidepressants	0.021	0.979
S00.8 Superficial injury of other parts of head	0.024	0.976
T43.0 Tricyclic and tetracyclic antidepressants	0.024	0.976
T81.4 Infection following a procedure, not elsewhere classified	0.026	0.974
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.026	0.974
F10.3 Withdrawal state	0.026	0.974
Chapter XII Diseases of the skin and subcutaneous tissue	0.032	0.968
Chapter IV Endocrine, nutritional and metabolic diseases	0.033	0.967
E11 Non-insulin-dependent diabetes mellitus	0.034	0.966
E10-E14 Diabetes mellitus	0.035	0.965
G90-G99 Other disorders of the nervous system	0.037	0.963
S09 Other and unspecified injuries of head	0.039	0.961
G62 Other polyneuropathies	0.042	0.958
L40-L45 Papulosquamous disorders	0.042	0.958
G62.9 Polyneuropathy, unspecified	0.047	0.953
I21 Acute myocardial infarction	0.052	0.948
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.055	0.945
L40 Psoriasis	0.059	0.941
T84.6 Infection and inflammatory reaction due to internal fixation device [any site]	0.063	0.937
T84.1 Mechanical complication of internal fixation device of bones of limb	0.063	0.937
G99 Other disorders of nervous system in diseases classified elsewhere	0.064	0.936
E11.4 With neurological complications	0.065	0.935
S09.9 Unspecified injury of head	0.066	0.934
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.073	0.927
S02 Fracture of skull and facial bones	0.078	0.922
E11.5 With peripheral circulatory complications	0.079	0.921
T50.9 Other and unspecified drugs, medicaments and biological substances	0.080	0.920
E11.9 Without complications	0.089	0.911
L40.5 Arthropathic psoriasis	0.090	0.910
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.097	0.903
I21.4 Acute subendocardial myocardial infarction	0.100	0.900
G99.2 Myelopathy in diseases classified elsewhere	0.100	0.900
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.103	0.897
T85 Complications of other internal prosthetic devices, implants and grafts	0.104	0.896
T82.3 Mechanical complication of other vascular grafts	0.108	0.892
C77.2 Intra-abdominal lymph nodes	0.110	0.890
S02.4 Fracture of malar and maxillary bones	0.113	0.887
T51.9 Alcohol, unspecified	0.116	0.884
S00.0 Superficial injury of scalp	0.116	0.884
Z95.9 Presence of cardiac and vascular implant and graft, unspecified	0.117	0.883
C77.0 Lymph nodes of head, face and neck	0.117	0.883
G40-G47 Episodic and paroxysmal disorders	0.118	0.882
T43.3 Phenothiazine antipsychotics and neuroleptics	0.120	0.880
L00-L08 Infections of the skin and subcutaneous tissue	0.120	0.880
G40 Epilepsy	0.120	0.880
L43 Lichen planus	0.120	0.880
I21.0 Acute transmural myocardial infarction of anterior wall	0.121	0.879
T84.5 Infection and inflammatory reaction due to internal joint prosthesis	0.122	0.878
S10-S19 Injuries to the neck	0.123	0.877
E50-E64 Other nutritional deficiencies	0.128	0.872
T81.0 Haemorrhage and haematoma complicating a procedure, not elsewhere classified	0.129	0.871
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.136	0.864
S02.40 Fracture of malar and maxillary bones (closed)	0.138	0.862
S00.2 Other superficial injuries of eyelid and periocular area	0.138	0.862
G95 Other diseases of spinal cord	0.141	0.859
E11.2 With renal complications	0.147	0.853
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.152	0.848
S06 Intracranial injury	0.156	0.844
G63 Polyneuropathy in diseases classified elsewhere	0.156	0.844
C77.3 Axillary and upper limb lymph nodes	0.157	0.843
L43.9 Lichen planus, unspecified	0.159	0.841
S20-S29 Injuries to the thorax	0.162	0.838
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.165	0.835
S32 Fracture of lumbar spine and pelvis	0.165	0.835
S01 Open wound of head	0.168	0.832
I21.2 Acute transmural myocardial infarction of other sites	0.178	0.822
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.180	0.820
G96 Other disorders of central nervous system	0.180	0.820
L40.0 Psoriasis vulgaris	0.182	0.818
L08 Other local infections of skin and subcutaneous tissue	0.185	0.815
T84.7 Infection and inflammatory reaction due to other internal orthopaedic prosthetic devices, implants and grafts	0.187	0.813
E10 Insulin-dependent diabetes mellitus	0.188	0.812
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.190	0.810
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.192	0.808
L20-L30 Dermatitis and eczema	0.194	0.806
T43.5 Other and unspecified antipsychotics and neuroleptics	0.198	0.802
S01.0 Open wound of scalp	0.199	0.801
T84.3 Mechanical complication of other bone devices, implants and grafts	0.199	0.801
E11.0 With coma	0.202	0.798
T81.7 Vascular complications following a procedure, not elsewhere classified	0.203	0.797
C77.1 Intrathoracic lymph nodes	0.204	0.796
G50-G59 Nerve, nerve root and plexus disorders	0.206	0.794
G99.0 Autonomic neuropathy in endocrine and metabolic diseases	0.207	0.793
S60-S69 Injuries to the wrist and hand	0.208	0.792
I25.3 Aneurysm of heart	0.210	0.789
E11.8 With unspecified complications	0.213	0.787
T85.5 Mechanical complication of gastro-intestinal prosthetic devices, implants and grafts	0.214	0.786
G90 Disorders of autonomic nervous system	0.215	0.785
C78.0 Secondary malignant neoplasm of lung	0.217	0.783
T85.6 Mechanical complication of other specified internal prosthetic devices, implants and grafts	0.217	0.783
S70-S79 Injuries to the hip and thigh	0.220	0.780
T82.2 Mechanical complication of coronary artery bypass and valve grafts	0.221	0.779
T81.3 Disruption of operation wound, not elsewhere classified	0.221	0.779
G91 Hydrocephalus	0.222	0.778
L30 Other dermatitis	0.222	0.777
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.224	0.776
G30-G32 Other degenerative diseases of the nervous system	0.224	0.776
E53 Deficiency of other B group vitamins	0.225	0.775
F11 Mental and behavioural disorders due to use of opioids	0.228	0.772
S30 Superficial injury of abdomen, lower back and pelvis	0.231	0.769
F00-F09 Organic, including symptomatic, mental disorders	0.235	0.765
L30.9 Dermatitis, unspecified	0.236	0.764
S02.0 Fracture of vault of skull	0.238	0.762
T84.9 Unspecified complication of internal orthopaedic prosthetic device, implant and graft	0.240	0.760
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.244	0.756
G60 Hereditary and idiopathic neuropathy	0.244	0.756
L08.8 Other specified local infections of skin and subcutaneous tissue	0.244	0.756
G55 Nerve root and plexus compressions in diseases classified elsewhere	0.244	0.756
F40-F48 Neurotic, stress-related and somatoform disorders	0.247	0.753
C79 Secondary malignant neoplasm of other sites	0.248	0.752
T82.4 Mechanical complication of vascular dialysis catheter	0.248	0.752
G63.2 Diabetic polyneuropathy	0.250	0.750
T84.2 Mechanical complication of internal fixation device of other bones	0.250	0.750
S62 Fracture at wrist and hand level	0.251	0.749
T82.0 Mechanical complication of heart valve prosthesis	0.252	0.748
F12 Mental and behavioural disorders due to use of cannabinoids	0.252	0.747
S00.7 Multiple superficial injuries of head	0.257	0.743
F80-F89 Disorders of psychological development	0.257	0.743
S32.0 Fracture of lumbar vertebra	0.258	0.742
C80 Malignant neoplasm without specification of site	0.260	0.740
G40.8 Other epilepsy	0.262	0.738
S39 Other and unspecified injuries of abdomen, lower back and pelvis	0.263	0.737
F10.9 Unspecified mental and behavioural disorder	0.264	0.736
S02.3 Fracture of orbital floor	0.265	0.735
S00.9 Superficial injury of head, part unspecified	0.266	0.734
S22 Fracture of rib(s), sternum and thoracic spine	0.266	0.734
L02 Cutaneous abscess, furuncle and carbuncle	0.266	0.734
G55.1 Nerve root and plexus compressions in intervertebral disk disorders	0.270	0.730
T39.0 Salicylates	0.271	0.729
L40.9 Psoriasis, unspecified	0.272	0.728
Chapter XXII Codes for special purposes	0.272	0.728
G95.2 Cord compression, unspecified	0.277	0.723
E61 Deficiency of other nutrient elements	0.279	0.721
E10.5 With peripheral circulatory complications	0.282	0.718
F10.5 Psychotic disorder	0.283	0.717
F10.7 Residual and late-onset psychotic disorder	0.283	0.717
F10.8 Other mental and behavioural disorders	0.283	0.717
I25.6 Silent myocardial ischaemia	0.283	0.717
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.283	0.717
T41 Poisoning by anaesthetics and therapeutic gases	0.283	0.717
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.283	0.717
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.283	0.717
T26-T28 Burns and corrosions confined to eye and internal organs	0.283	0.717
T33-T35 Frostbite	0.283	0.717
I00-I02 Acute rheumatic fever	0.283	0.717
S04 Injury of cranial nerves	0.283	0.717
S07 Crushing injury of head	0.283	0.717
S08 Traumatic amputation of part of head	0.283	0.717
Chapter XVI Certain conditions originating in the perinatal period	0.283	0.717
I13 Hypertensive heart and renal disease	0.283	0.716
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.283	0.716
T43.6 Psychostimulants with abuse potential	0.283	0.716
T43.8 Other psychotropic drugs, not elsewhere classified	0.283	0.716
T43.9 Psychotropic drug, unspecified	0.283	0.716
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.283	0.716
F14 Mental and behavioural disorders due to use of cocaine	0.283	0.716
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.283	0.716
F16 Mental and behavioural disorders due to use of hallucinogens	0.283	0.716
F18 Mental and behavioural disorders due to use of volatile solvents	0.283	0.716
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.283	0.716
T55 Toxic effect of soaps and detergents	0.284	0.716
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.284	0.716
T52 Toxic effect of organic solvents	0.284	0.716
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.284	0.716
T54 Toxic effect of corrosive substances	0.284	0.716
T57 Toxic effect of other inorganic substances	0.284	0.716
T59 Toxic effect of other gases, fumes and vapours	0.284	0.716
T60 Toxic effect of pesticides	0.284	0.716
T61 Toxic effect of noxious substances eaten as seafood	0.284	0.716
T62 Toxic effect of other noxious substances eaten as food	0.284	0.716
T65 Toxic effect of other and unspecified substances	0.284	0.716
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.284	0.716
T42.1 Iminostilbenes	0.284	0.716
T42.2 Succinimides and oxazolidinediones	0.284	0.716
T42.3 Barbiturates	0.284	0.716
T42.5 Mixed antiepileptics, not elsewhere classified	0.284	0.716
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.284	0.716
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.284	0.716
S01.5 Open wound of lip and oral cavity	0.284	0.716
T51.1 Methanol	0.284	0.716
T51.2 2-Propanol	0.284	0.716
T51.3 Fusel oil	0.284	0.716
T51.8 Other alcohols	0.284	0.716
I15 Secondary hypertension	0.284	0.716
G96.0 Cerebrospinal fluid leak	0.284	0.716
T43.4 Butyrophenone and thioxanthene neuroleptics	0.285	0.715
T56 Toxic effect of metals	0.286	0.714
S62.3 Fracture of other metacarpal bone	0.289	0.711
T39.2 Pyrazolone derivatives	0.290	0.710
T39.4 Antirheumatics, not elsewhere classified	0.290	0.710
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.290	0.710
S02.8 Fractures of other skull and facial bones	0.291	0.709
E40-E46 Malnutrition	0.291	0.709
G95.9 Disease of spinal cord, unspecified	0.293	0.707
F10.4 Withdrawal state with delirium	0.294	0.706
S19 Other and unspecified injuries of neck	0.294	0.706
T85.8 Other complications of internal prosthetic devices, implants and grafts, not elsewhere classified	0.294	0.706
G40.9 Epilepsy, unspecified	0.294	0.706
T82.9 Unspecified complication of cardiac and vascular prosthetic device, implant and graft	0.294	0.706
E53.8 Deficiency of other specified B group vitamins	0.295	0.705
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.295	0.705
T81.5 Foreign body accidentally left in body cavity or operation wound following a procedure	0.296	0.704
S00.5 Superficial injury of lip and oral cavity	0.296	0.704
G62.0 Drug-induced polyneuropathy	0.297	0.703
T81.6 Acute reaction to foreign substance accidentally left during a procedure	0.297	0.703
T85.3 Mechanical complication of other ocular prosthetic devices, imnplants and grafts	0.298	0.702
C80.9 Malignant neoplasm, unspecified	0.298	0.702
F70-F79 Mental retardation	0.300	0.700
G64 Other disorders of peripheral nervous system	0.302	0.698
Z95.3 Presence of xenogenic heart valve	0.302	0.698
T40.2 Other opioids	0.303	0.697
L80-L99 Other disorders of the skin and subcutaneous tissue	0.304	0.696
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.304	0.695
G80-G83 Cerebral palsy and other paralytic syndromes	0.305	0.695
L97 Ulcer of lower limb, not elsewhere classified	0.306	0.694
S29 Other and unspecified injuries of thorax	0.306	0.694
T82.6 Infection and inflammatory reaction due to cardiac valve prosthesis	0.307	0.693
E11.7 With multiple complications	0.307	0.693
I50.9 Heart failure, unspecified	0.307	0.693
I25.4 Coronary artery aneurysm	0.307	0.693
L05 Pilonidal cyst	0.307	0.693
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.308	0.692
E12 Malnutrition-related diabetes mellitus	0.308	0.692
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.308	0.692
S13 Dislocation, sprain and strain of joints and ligaments at neck level	0.308	0.692
G92 Toxic encephalopathy	0.309	0.691
S09.8 Other specified injuries of head	0.310	0.690
S09.0 Injury of blood vessels of head, not elsewhere classified	0.311	0.689
S09.1 Injury of muscle and tendon of head	0.311	0.689
S09.2 Traumatic rupture of ear drum	0.311	0.689
S09.7 Multiple injuries of head	0.311	0.689
E11.1 With ketoacidosis	0.311	0.689
Z95.2 Presence of prosthetic heart valve	0.311	0.689
S10 Superficial injury of neck	0.312	0.688
F45 Somatoform disorders	0.312	0.688
G62.1 Alcoholic polyneuropathy	0.313	0.687
G62.2 Polyneuropathy due to other toxic agents	0.313	0.687
L45 Papulosquamous disorders in diseases classified elsewhere	0.313	0.687
L41 Parapsoriasis	0.313	0.687
L44 Other papulosquamous disorders	0.313	0.687
S62.6 Fracture of other finger	0.315	0.685
E10.4 With neurological complications	0.315	0.685
T82.5 Mechanical complication of other cardiac and vascular devices and implants	0.316	0.684
G59 Mononeuropathy in diseases classified elsewhere	0.316	0.684
S69 Other and unspecified injuries of wrist and hand	0.316	0.684
S62.30 Fracture of other metacarpal bone (closed)	0.317	0.683
I23 Certain current complications following acute myocardial infarction	0.317	0.683
I50 Heart failure	0.318	0.682
T92 Sequelae of injuries of upper limb	0.319	0.681
T40.6 Other and unspecified narcotics	0.320	0.680
I21.X Presumed acute myicardial infaction (unconfirmed)	0.320	0.680
S14 Injury of nerves and spinal cord at neck level	0.320	0.680
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.322	0.678
T50.0 Mineralocorticoids and their antagonists	0.323	0.677
T50.1 Loop [high-ceiling] diuretics	0.323	0.677
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.323	0.677
T50.3 Electrolytic, caloric and water-balance agents	0.323	0.677
T50.4 Drugs affecting uric acid metabolism	0.323	0.677
T50.5 Appetite depressants	0.323	0.677
T50.7 Analeptics and opioid receptor antagonists	0.323	0.677
T50.8 Diagnostic agents	0.323	0.677
G30 Alzheimer's disease	0.324	0.676
S32.00 Fracture of lumbar vertebra (closed)	0.324	0.676
F43 Reaction to severe stress, and adjustment disorders	0.324	0.676
E11.6 With other specified complications	0.324	0.676
L40.1 Generalised pustular psoriasis	0.325	0.675
L40.2 Acrodermatitis continua	0.325	0.675
L40.3 Pustulosis palmaris et plantaris	0.325	0.675
L40.4 Guttate psoriasis	0.325	0.675
L40.8 Other psoriasis	0.325	0.675
S01.4 Open wound of cheek and temporomandibular area	0.325	0.675
I30-I52 Other forms of heart disease	0.327	0.673
T58 Toxic effect of carbon monoxide	0.327	0.672
T85.4 Mechanical complication of breast prosthesis and implant	0.328	0.672
G91.9 Hydrocephalus, unspecified	0.328	0.672
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.328	0.671
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere	0.329	0.671
G99.8 Other specified disorders of nervous system in diseases classified elsewhere	0.329	0.671
T85.2 Mechanical complication of intraocular lens	0.329	0.671
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.329	0.671
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.330	0.670
C78.7 Secondary malignant neoplasm of liver	0.332	0.668
G40.5 Special epileptic syndromes	0.333	0.667
T00-T07 Injuries involving multiple body regions	0.334	0.666
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.335	0.665
S02.7 Multiple fractures involving skull and facial bones	0.335	0.665
S33 Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis	0.335	0.665
S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level	0.335	0.665
S35 Injury of blood vessels at abdomen, lower back and pelvis level	0.335	0.665
S36 Injury of intra-abdominal organs	0.335	0.665
S37 Injury of urinary and pelvic organs	0.335	0.665
S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis	0.335	0.665
F29 Unspecified nonorganic psychosis	0.336	0.664
T87 Complications peculiar to reattachment and amputation	0.336	0.664
S06.5 Traumatic subdural haemorrhage	0.342	0.658
S06.0 Concussion	0.344	0.656
L10-L14 Bullous disorders	0.346	0.654
S32.8 Fracture of other and unspecified parts of lumbar spine and pelvis	0.348	0.652
S06.8 Other intracranial injuries	0.349	0.651
S72 Fracture of femur	0.350	0.650
E10.1 With ketoacidosis	0.351	0.649
G55.0 Nerve root and plexus compressions in neoplastic disease	0.351	0.649
S05 Injury of eye and orbit	0.351	0.649
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.351	0.649
T85.1 Mechanical complication of implanted electronic stimulator of nervous system	0.352	0.648
S02.00 Fracture of vault of skull (closed)	0.352	0.648
T42.0 Hydantoin derivatives	0.354	0.646
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation	0.354	0.646
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk	0.357	0.643
G95.1 Vascular myelopathies	0.357	0.643
G95.0 Syringomyelia and syringobulbia	0.358	0.642
F05 Delirium, not induced by alcohol and other psychoactive substances	0.358	0.642
S22.0 Fracture of thoracic vertebra	0.358	0.642
T85.9 Unspecified complication of internal prosthetic device, implant and graft	0.359	0.641
S32.4 Fracture of acetabulum	0.359	0.641
F45.8 Other somatoform disorders	0.359	0.641
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.360	0.640
G50 Disorders of trigeminal nerve	0.362	0.638
T46 Poisoning by agents primarily affecting the cardiovascular system	0.363	0.636
S06.4 Epidural haemorrhage	0.363	0.636
S02.41 Fracture of malar and maxillary bones (open)	0.364	0.636
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.364	0.636
C77.4 Inguinal and lower limb lymph nodes	0.365	0.635
S32.3 Fracture of ilium	0.365	0.634
I25.0 Atherosclerotic cardiovascular disease, so described	0.366	0.634
C79.8 Secondary malignant neoplasm of other specified sites	0.366	0.634
S06.3 Focal brain injury	0.367	0.633
L08.9 Local infection of skin and subcutaneous tissue, unspecified	0.367	0.633
S03 Dislocation, sprain and strain of joints and ligaments of head	0.367	0.633
G46 Vascular syndromes of brain in cerebrovascular diseases	0.367	0.632
L00 Staphylococcal scalded skin syndrome	0.369	0.631
L01 Impetigo	0.369	0.631
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.369	0.631
G40.4 Other generalised epilepsy and epileptic syndromes	0.369	0.631
L43.0 Hypertrophic lichen planus	0.369	0.631
L43.1 Bullous lichen planus	0.369	0.631
L43.2 Lichenoid drug reaction	0.369	0.631
L43.3 Subacute (active) lichen planus	0.369	0.631
S16 Injury of muscle and tendon at neck level	0.371	0.629
S18 Traumatic amputation at neck level	0.371	0.629
S15 Injury of blood vessels at neck level	0.371	0.629
S17 Crushing injury of neck	0.371	0.629
G90.0 Idiopathic peripheral autonomic neuropathy	0.371	0.629
S62.61 Fracture of other finger (open)	0.373	0.627
E10.3 With ophthalmic complications	0.373	0.627
T63 Toxic effect of contact with venomous animals	0.373	0.627
S11 Open wound of neck	0.373	0.626
L05.9 Pilonidal cyst without abscess	0.374	0.626
E52 Niacin deficiency [pellagra]	0.374	0.625
E54 Ascorbic acid deficiency	0.374	0.625
E58 Dietary calcium deficiency	0.374	0.625
E59 Dietary selenium deficiency	0.374	0.625
E60 Dietary zinc deficiency	0.374	0.625
E50 Vitamin A deficiency	0.374	0.625
E51 Thiamine deficiency	0.374	0.625
E56 Other vitamin deficiencies	0.374	0.625
E63 Other nutritional deficiencies	0.374	0.625
E64 Sequelae of malnutrition and other nutritional deficiencies	0.374	0.625
G40.7 Petit mal, unspecified, without grand mal seizures	0.375	0.625
S06.6 Traumatic subarachnoid haemorrhage	0.376	0.624
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.377	0.623
S00.4 Superficial injury of ear	0.377	0.623
T86 Failure and rejection of transplanted organs and tissues	0.377	0.623
S67 Crushing injury of wrist and hand	0.377	0.623
T81.1 Shock during or resulting from a procedure, not elsewhere classified	0.377	0.623
S79 Other and unspecified injuries of hip and thigh	0.377	0.623
S69.9 Unspecified injury of wrist and hand	0.379	0.621
F22 Persistent delusional disorders	0.380	0.619
I25.5 Ischaemic cardiomyopathy	0.382	0.618
G55.2 Nerve root and plexus compressions in spondylosis	0.382	0.618
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.382	0.618
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.382	0.618
L20 Atopic dermatitis	0.386	0.614
F20 Schizophrenia	0.387	0.613
T98 Sequelae of other and unspecified effects of external causes	0.387	0.613
F43.2 Adjustment disorders	0.387	0.613
S30.0 Contusion of lower back and pelvis	0.387	0.612
E61.1 Iron deficiency	0.388	0.612
G98 Other disorders of nervous system, not elsewhere classified	0.388	0.611
F01 Vascular dementia	0.389	0.611
T36 Poisoning by systemic antibiotics	0.389	0.611
G90.9 Disorder of autonomic nervous system, unspecified	0.390	0.610
S32.1 Fracture of sacrum	0.391	0.609
F11.2 Dependence syndrome	0.391	0.609
S22.3 Fracture of rib	0.392	0.608
T40.0 Opium	0.392	0.608
T40.1 Heroin	0.392	0.608
T40.3 Methadone	0.392	0.608
T40.5 Cocaine	0.392	0.608
T40.7 Cannabis (derivatives)	0.392	0.608
T40.8 Lysergide [LSD]	0.392	0.608
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.392	0.608
C78.4 Secondary malignant neoplasm of small intestine	0.394	0.606
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified	0.394	0.606
S06.1 Traumatic cerebral oedema	0.394	0.605
S06.7 Intracranial injury with prolonged coma	0.394	0.605
S66 Injury of muscle and tendon at wrist and hand level	0.395	0.605
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere	0.395	0.605
G63.1 Polyneuropathy in neoplastic disease	0.395	0.605
G63.3 Polyneuropathy in other endocrine and metabolic diseases	0.395	0.605
G63.4 Polyneuropathy in nutritional deficiency	0.395	0.605
G63.5 Polyneuropathy in systemic connective tissue disorders	0.395	0.605
G63.6 Polyneuropathy in other musculoskeletal disorders	0.395	0.605
G63.8 Polyneuropathy in other diseases classified elsewhere	0.395	0.605
L93 Lupus erythematosus	0.395	0.605
S19.9 Unspecified injury of neck	0.395	0.605
G59.0 Diabetic mononeuropathy	0.395	0.605
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.396	0.604
F81 Specific developmental disorders of scholastic skills	0.397	0.603
T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts	0.397	0.603
L02.1 Cutaneous abscess, furuncle and carbuncle of neck	0.399	0.601
S23 Dislocation, sprain and strain of joints and ligaments of thorax	0.399	0.601
S24 Injury of nerves and spinal cord at thorax level	0.399	0.601
S25 Injury of blood vessels of thorax	0.399	0.601
S26 Injury of heart	0.399	0.601
S28 Crushing injury of thorax and traumatic amputation of part of thorax	0.399	0.601
S02.30 Fracture of orbital floor (closed)	0.399	0.601
T79-T79 Certain early complications of trauma	0.399	0.601
G60.0 Hereditary motor and sensory neuropathy	0.400	0.600
G90.2 Horner's syndrome	0.400	0.600
T40.4 Other synthetic narcotics	0.401	0.599
S32.2 Fracture of coccyx	0.401	0.599
G30.9 Alzheimer's disease, unspecified	0.401	0.599
S12 Fracture of neck	0.402	0.598
F23 Acute and transient psychotic disorders	0.402	0.598
F17 Mental and behavioural disorders due to use of tobacco	0.403	0.597
G53 Cranial nerve disorders in diseases classified elsewhere	0.403	0.596
S01.9 Open wound of head, part unspecified	0.404	0.596
E55 Vitamin D deficiency	0.405	0.595
S72.0 Fracture of neck of femur	0.405	0.595
C78.1 Secondary malignant neoplasm of mediastinum	0.406	0.594
G41 Status epilepticus	0.406	0.594
G96.1 Disorders of meninges, not elsewhere classified	0.407	0.593
S22.1 Multiple fractures of thoracic spine	0.409	0.591
S29.9 Unspecified injury of thorax	0.409	0.591
S02.9 Fracture of skull and facial bones, part unspecified	0.409	0.590
S06.2 Diffuse brain injury	0.409	0.590
C77.5 Intrapelvic lymph nodes	0.410	0.590
S02.6 Fracture of mandible	0.410	0.590
I21.3 Acute transmural myocardial infarction of unspecified site	0.411	0.589
F10.6 Amnesic syndrome	0.411	0.589
S31 Open wound of abdomen, lower back and pelvis	0.411	0.589
L83 Acanthosis nigricans	0.411	0.589
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.412	0.588
G96.8 Other specified disorders of central nervous system	0.412	0.588
G96.9 Disorder of central nervous system, unspecified	0.412	0.588
G95.8 Other specified diseases of spinal cord	0.414	0.586
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.414	0.586
F00 Dementia in Alzheimer's disease	0.416	0.584
L08.0 Pyoderma	0.416	0.584
L08.1 Erythrasma	0.416	0.584
E10.2 With renal complications	0.418	0.582
E10.6 With other specified complications	0.418	0.582
E10.7 With multiple complications	0.418	0.582
E10.8 With unspecified complications	0.418	0.582
F21 Schizotypal disorder	0.419	0.581
F24 Induced delusional disorder	0.419	0.581
F28 Other nonorganic psychotic disorders	0.419	0.581
G97 Postprocedural disorders of nervous system, not elsewhere classified	0.420	0.580
L04 Acute lymphadenitis	0.421	0.578
G58 Other mononeuropathies	0.422	0.578

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant cluster associations

Hospitalization Episode Statistics (`HES`)

Variant cluster associations

Hospitalization Episode Statistics (HES)

Hospitalization Episode Statistics (`HES`)